Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer

NCT00071058 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

Adrenal Cortex Neoplasms

Interventions

DRUG: XR9576 (Tariquidar)

Sponsor

National Cancer Institute (NCI)